PineTree Therapeutics
About:
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Website: https://www.pinetreetx.com/
Top Investors: Massachusetts Life Sciences Center, Schmidt, InterVest Co., STIC Investment, DSC Investment
Description:
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Total Funding Amount:
$40.5M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2019-01-01
Founders:
Ho-Juhn Song
Number of Employees:
11-50
Last Funding Date:
2024-07-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai